New womb cancer treatment gives hope for hundreds of women
A drug that could buy women with womb cancer more time with their loved ones before the disease progresses is to be made available on the NHS.
Dostarlimab, which is sold under the brand name Jemperli, is an immunotherapy that works by attracting specific proteins on the surface of cancer cells to help the immune system attack them.
The move is expected to benefit
